Avidity Biosciences, Inc. (NASDAQ:RNA) Stock Holdings Increased by Rhumbline Advisers
Rhumbline Advisers boosted its position in Avidity Biosciences, Inc. (NASDAQ:RNA – Free Report) by 7.1% in the 1st quarter, according to the company in its most recent Form 13F filing with the Securities & Exchange Commission. The fund owned 164,776 shares of the biotechnology company’s stock after buying an additional 10,973 shares during the quarter. […]
Rhumbline Advisers boosted its position in Avidity Biosciences, Inc. (NASDAQ:RNA – Free Report) by 7.1% in the 1st quarter, according to the company in its most recent Form 13F filing with the Securities & Exchange Commission. The fund owned 164,776 shares of the biotechnology company’s stock after buying an additional 10,973 shares during the quarter. […]
